{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:23:27Z","timestamp":1767983007625,"version":"3.49.0"},"reference-count":64,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Immunogenic cell death (ICD) is a regulated form of cell death that elicits an adaptive immune response, recognized as a promising strategy in cancer immunotherapy. Its therapeutic efficacy, however, can be influenced by tumor-intrinsic factors, particularly in heterogeneous diseases like breast cancer (BC). This study investigated the ICD-related gene expression signature in BC using the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) cohorts. Analysis revealed significantly elevated expression of HSP90AA1, CXCR3, MYD88, FOXP3, PDIA3, XBP1, and IFNB1, and reduced expression of P2RX7 in BC tissues compared with normal tissues. Furthermore, the expression of these genes varied significantly across distinct BC subtypes, patient ages, and tumor stages. Concurrently, an investigation into the UPR pathway, known to intersect with ICD, highlighted Binding immunoglobulin Protein (BiP\/GRP78\/HSPA5) as a molecule of interest. To explore potential modulators of this pathway, &lt;i&gt;in silico&lt;\/i&gt; docking studies were performed, which predicted favorable binding interactions of quercetin and taxifolin with BiP. These findings suggest that characterizing the expression patterns of these ICD-related genes and UPR components could inform the development of personalized immunotherapeutic strategies for BC, tailored to specific tumor subtypes, stages, and patient demographics. Further exploration of BiP's role and its potential for therapeutic manipulation may offer novel avenues to enhance anti-tumor immunity.<\/p>","DOI":"10.1615\/critrevoncog.2025059938","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:26:22Z","timestamp":1749720382000},"page":"33-51","source":"Crossref","is-referenced-by-count":1,"title":["Research Article: Immunogenic Cell Death-Related Gene Expression Signatures in Breast Cancer Subtypes: A TCGA- and GEO-Based Analysis with Potential Therapeutic Implications"],"prefix":"10.1615","volume":"30","author":[{"given":"Faustine","family":"Marius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama Rao","family":"Malla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. Breast cancer: Pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49.","DOI":"10.1038\/s41392-024-02108-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u00c5\u0082awek A. Breast cancer-Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-An updated review. Cancers. 2021;13(17):4287.","DOI":"10.3390\/cancers13174287"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Barzegar F, Pahlavan Yali Z, Fatemi MH. Study the inhibitory effect of some plant origin flavonoids against targetable cancer receptors GRP78 by molecular docking. Netw Model Anal Health Inform Bioinform. 2021;10:1-9.","DOI":"10.1007\/s13721-021-00308-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Malla R, Jyosthsna K, Rani G, Purnachandra Nagaraju G. CD44\/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds. Int Immunopharmacol. 2024;138:112613.","DOI":"10.1016\/j.intimp.2024.112613"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Zhao R, Xie C, Gong Y, Wei S, Yuan M, Gan J, Chen W. A novel inflammatory response-related gene signature predicts immune status and prognosis of breast cancer. J Oncol. 2022;2022:5468858.","DOI":"10.1155\/2022\/5468858"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Li J, Li Z, Yang W, Pan J, You H, Yang L, Zhang X. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer. Cancer Rep. 2024;7(3):e2007.","DOI":"10.1002\/cnr2.2007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Li Y, Feng J, Wang T, Li M, Zhang H, Rong Z, Cheng W, Duan Y, Chen Z, Hu A, Yu T, Zhang J, Shang Y, Zou Y, Ma F, Guo B. Construction of an immunogenic cell deathbased risk score prognosis model in breast cancer. Front Genet. 2022;13:1069921.","DOI":"10.3389\/fgene.2022.1069921"},{"key":"9","unstructured":"Cheng XY, Liang Y, Zhang HF, Qian FZ, Sun XH, Liu XA. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer. Am J Transl Res. 2023;15(4):2598-609."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Zhu L, Wu Y, Zhao H, Guo Z, Bo B, Zheng L. Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer. Sci Rep. 2024;14(1):2025.","DOI":"10.1038\/s41598-024-52353-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Zhao R, Wang W, Pan L, Lv X, He Y, Lian W, Ma Y, Zhang X, Yu R, Zhao S, Guo X, Huang T, Peng M. The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer. Front Oncol. 2023;13:1047973.","DOI":"10.3389\/fonc.2023.1047973"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Zhang J, Shi X, Wang M, Zhai R, Wang M, Gong Z, Ni Z, Xu T, Zhu W, Liu L. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2024;150(5):240.","DOI":"10.1007\/s00432-024-05779-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Choi M, Shin J, Lee CE, Chung JY, Kim M, Yan X, Yang WH, Cha JH. Immunogenic cell death in cancer immunotherapy. BMB Rep. 2023;56(5):275-86.","DOI":"10.5483\/BMBRep.2023-0024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Pol JG, Plantureux C, P\u00e9rez-Lanz\u00f3n M, Kroemer G. PDIA3 as a potential bridge between immunogenic cell death and autoreactivity. Oncoimmunology. 2022;11(1):2130558","DOI":"10.1080\/2162402X.2022.2130558"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Jiang Y, Yang L, Jiang L, Yu W, Jin Z, Qiu Y, Liao Y, Liu J, Zhang H. X-box binding protein 1 is a potential immunotherapy target in ovarian cancer. Front Genet. 2022;13:818917.","DOI":"10.3389\/fgene.2022.818917"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Zou YT, Li JY, Chai JY, Hu YS, Zhang WJ, Zhang Q. The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression. Biochem Biophys Res Commun. 2024;707:149513.","DOI":"10.1016\/j.bbrc.2024.149513"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Vandenbroeck K, Martens E, Alloza I. Multi-chaperone complexes regulate the folding of interferon-gamma in the endoplasmic reticulum. Cytokine. 2006;33(5):264-73.","DOI":"10.1016\/j.cyto.2006.02.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Zhang LL, Zhang DJ, Shi JX, Huang MY, Yu JM, Chen XJ, Wei X, Zou L, Lu JJ. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products. Phytomedicine. 2024;132:155828.","DOI":"10.1016\/j.phymed.2024.155828"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Amiri M, Molavi O, Sabetkam S, Jafari S, Montazersaheb S. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds. Cancer Cell Int. 2023;23(1):200.","DOI":"10.1186\/s12935-023-03058-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kepp O, Bezu L, Kroemer G. The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers? Oncoimmunology. 2022;11(1):2092328.","DOI":"10.1080\/2162402X.2022.2092328"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Bhamidipati P, Nagaraju GP, Malla R. Immunoglobulin-binding protein and Toll-like receptors in immune landscape of breast cancer. Life Sci. 2024;358:123196.","DOI":"10.1016\/j.lfs.2024.123196"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wang N, Wang Z, Peng C, You J, Shen J, Han S, Chen J. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via B-catenin\/ABCG2 signaling. Carcinogenesis. 2014;35(11):2544-54.","DOI":"10.1093\/carcin\/bgu187"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Chen JL, Tai YS, Tsai HY, Hsieh CY, Chen CL, Liu CJ, Wu DC, Huang YB, Lin MW. Betulinic acid inhibits the stemness of gastric cancer cells by regulating the GRP78-TGF-B1 signaling pathway and macrophage polarization. Molecules. 2023;28(4):1725.","DOI":"10.3390\/molecules28041725"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Capriglione F, Maiuolo J, Celano M, Damante G, Russo D, Bulotta S, Maggisano V. Quercetin protects human thyroid cells against cadmium toxicity. Int J Mol Sci. 2021;22(13):6849.","DOI":"10.3390\/ijms22136849"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Li C, Zhang B, Lv W, Lai C, Chen Z, Wang R, Long X, Feng X. Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells. Oncotarget. 2016;7(31):49588-96.","DOI":"10.18632\/oncotarget.10412"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kusaczuk M, Tovar-Ambel E, Martin-Cabrera P, Lorente M, Salvador-Tormo N, Miklosz A, Chabowski A, Velasco G, Naumowicz M. Cytotoxicity, proapoptotic activity and drug-like potential of quercetin and kaempferol in glioblastoma cells: Preclinical insights. Int J Mol Sci. 2024;25(19):10740.","DOI":"10.3390\/ijms251910740"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Wu MH, Hsieh YH, Lin CL, Ying TH, Hsia SM, Hsieh SC, Lee CH, Lin CL. Licochalcone A induces endoplasmic reticulum stress-mediated apoptosis of endometrial cancer cells via upregulation of GRP78 expression. Environ Toxicol. 2024;39(5):2961-9.","DOI":"10.1002\/tox.24156"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Yu JS, Kim AK. Platycodin D induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells. J Med Food. 2012;15(8):691-9.","DOI":"10.1089\/jmf.2011.2024"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Mirza MA, Mahmood S, Hilles AR, Ali A, Khan MZ, Zaidi SaA, Iqbal Z, Ge Y. Quercetin as a therapeutic product: Evaluation of its pharmacological action and clinical applications-a review. Pharmaceuticals. 2023;16(11):1631.","DOI":"10.3390\/ph16111631"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhang J, Shen L, Li X, Song W, Liu Y, Huang L. Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer. ACS Nano. 2019;13(11):12511-24.","DOI":"10.1021\/acsnano.9b02875"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Sun D, Zou Y, Song L, Han S, Yang H, Chu D, Dai Y, Ma J, O'driscoll CM, Yu Z. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B. 2022;12(1):378-93.","DOI":"10.1016\/j.apsb.2021.06.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang L, He S, Liu R, Xue Y, Quan Y, Shi R, Yang X, Lin Q, Sun X, Zhang Z, Zhang L. A pH\/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment. Acta Pharm Sin B. 2024;14(5):2263-80.","DOI":"10.1016\/j.apsb.2023.12.001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhao P, Wang S, Jiang J, Gao Y, Wang Y, Zhao Y, Zhang J, Zhang M, Huang Y. Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery. J Control Release. 2023;358:706-17.","DOI":"10.1016\/j.jconrel.2023.05.024"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Kundrapu DB, Chaitanya AK, Manaswi K, Kumari S, Malla R. Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel-resistant breast cancer cells: An in silico and in vitro study. Chem Biol Drug Des. 2024;104(2):e14600.","DOI":"10.1111\/cbdd.14600"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Kundrapu DB, Rao PA, Malla RR. Enhanced efficacy of quercetin and taxifolin encapsulated with pH-responsive injectable BSA hydrogel for targeting triple-negative breast cancer cells. Int J Biol Macromol. 2025;287:138477.","DOI":"10.1016\/j.ijbiomac.2024.138477"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Han M, Zhu X, Li D, Si Q, Zhu T, Zhou Z, Liu G, Ren D, Jiang Q, Tang S. Quercetin and taxifolin enhance immunity in Chinese sucker (Myxocyprinus asiaticus) and increase its resistance to Aeromonas hydrophila. Comp Biochem Physiol Part D Genom Proteom. 2025;54:101369.","DOI":"10.1016\/j.cbd.2024.101369"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Zhang J, Trojel-Hansen C, Wang J, Zhang Z, Wang X, Qiao Y, Jiao H, Michaud M, Kepp O, J\u00e4\u00e4ttel\u00e4 M, Kroemer G, Zhong Q. Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells. Cell Death Dis. 2023;14(4):238.","DOI":"10.1038\/s41419-023-05740-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Song Q, Zhou Z, Bai J, Liu N. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer. Clin Transl Oncol. 2023;25(8):2587-606.","DOI":"10.1007\/s12094-023-03143-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Hu CY, Yin YF, Xu DP, Xu Y, Yang JY, Xu YN, Hua R. Construction and validation of immunogenic cell death-related molecular clusters, signature, and immune landscape in pancreatic cancer. Clin Exp Med. 2024;25(1):19.","DOI":"10.1007\/s10238-024-01533-7"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Jin S, Chen J. Exploring the prognostic significance of immunogenic cell death-related genes as risk biomarkers in cervical cancer. Immun Inflamm Dis. 2024;12(6):e1260.","DOI":"10.1002\/iid3.1260"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Wu E, Yin X, Liang F, Zhou X, Hu J, Yuan W, Gu F, Zhao J, Gao Z, Cheng M, Yang S, Zhang L, Wang Q, Sun X, Shao W. Analysis of immunogenic cell death in periodontitis based on scRNA-seq and bulk RNA-seq data. Front Immunol. 2024;15:1438998.","DOI":"10.3389\/fimmu.2024.1438998"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SaH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649-58.","DOI":"10.1016\/j.neo.2017.05.002"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zhang X, Liu T, Hao Y, Guo H, Li B. Functional exploration and drug prediction on programmed cell death-related biomarkers in lung adenocarcinoma. Heliyon. 2024;10(17):e36616.","DOI":"10.1016\/j.heliyon.2024.e36616"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010; 38(Web Server issue):W214-20.","DOI":"10.1093\/nar\/gkq537"},{"key":"45","doi-asserted-by":"crossref","unstructured":"J\u00e9r\u00f4me E, Santos-Martins D, Tillack A, Forli S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61(8):3891-8.","DOI":"10.1021\/acs.jcim.1c00203"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Emisoglu-Kulahli H, Gul S, Morgil H, Ozcan O, Aygenli F, Selvi S, Kavakli IH, Ozturk N. Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects. Funct Integr Genom. 2021;21(1):1-16.","DOI":"10.1007\/s10142-020-00757-6"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Zhang J, Trojel-Hansen C, Wang J, Zhang Z, Wang X, Qiao Y, Jiao H, Michaud M, Kepp O, J\u00e4\u00e4ttel\u00e4 M, Kroemer G, Zhong Q. Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells. Cell Death Dis. 2023;14(4):238.","DOI":"10.1038\/s41419-023-05740-0"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Zhou J, Wang G, Chen Y, Wang H, Hua Y, Cai Z. Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med. 2019;23(8):4854-65.","DOI":"10.1111\/jcmm.14356"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Xu M, Lu JH, Zhong YZ, Jiang J, Shen YZ, Su JY, Lin SY. Immunogenic cell death-relevant damage-associated molecular patterns and sensing receptors in triple-negative breast cancer molecular subtypes and implications for immunotherapy. Front Oncol. 2022;12:870914.","DOI":"10.3389\/fonc.2022.870914"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Calvillo-Rodr\u00edguez KM, Lorenzo-Anota HY, Rodr\u00edguez-Padilla C, Mart\u00ef\u00bf\u00bdnez-Torres AC, Scott-Algara D. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. Front Immunol. 2023;14:1294434.","DOI":"10.3389\/fimmu.2023.1294434"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Cava C, Pisati M, Frasca M, Castiglioni I. Identification of breast cancer subtype-specific biomarkers by integrating copy number alterations and gene expression profiles. Medicina. 2021;57(3):261.","DOI":"10.3390\/medicina57030261"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Wang Y, Yang R, Xie Y, Zhou XQ, Yang JF, Shi YY, Liu S. Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects. Clin Exp Med. 2024;24(1):230.","DOI":"10.1007\/s10238-024-01482-1"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang Z, Huang Y, Wei W, Ning S, Li J, Liang X, Liu K, Zhang L. Plasma HSP90AA1 predicts the risk of breast cancer onset and distant metastasis. Front Cell Dev Biol. 2021;9:639596.","DOI":"10.3389\/fcell.2021.639596"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Kuo AH, Scheeren FA. Cell-intrinsic TLR2\/MyD88 pathway in breast and colon cancer. Cell Cycle. 2014;13(24):3785-6.","DOI":"10.4161\/15384101.2014.989947"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Ramos FS, Serino LT, Carvalho CM, Lima RS, Urban CA, Cavalli IJ, Ribeiro EM. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer. Genet Mol Res. 2015;14(2):6960-7.","DOI":"10.4238\/2015.June.26.4"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Wang YY, Geng SK, Fu YP, Sun J. XBP1: A key regulator in breast cancer development and treatment. Pathol Res Pract. 2025;269:155900.","DOI":"10.1016\/j.prp.2025.155900"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, Soria JC, Zitvogel L, Kroemer G. Lossof-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 2012;1(3):271-8.","DOI":"10.4161\/onci.18684"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Gedik ME, Saatci O, Oberholtzer N, Uner M, Akbulut Caliskan O, Cetin M, Aras M, Ibis K, Caliskan B, Banoglu E, Wiemann S, \u00dcner A, Aksoy S, Mehrotra S, Sahin O. Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer Res. 2024;84(9):1475-90.","DOI":"10.1158\/0008-5472.CAN-23-2812"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Han X, Song D, Cui Y, Shi Y, Gu X. Pan-cancer analyses of immunogenic cell death-derived gene signatures: Potential biomarkers for prognosis and immunotherapy. Cancer Rep. 2024;7(4):e2073.","DOI":"10.1002\/cnr2.2073"},{"key":"60","doi-asserted-by":"crossref","unstructured":"D\u00e9ry MA, Jodoin J, Ursini-Siegel J, Aleynikova O, Ferrario C, Hassan S, Basik M, Leblanc AC. Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer. Breast Cancer Res. 2013;15(2):R22.","DOI":"10.1186\/bcr3398"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Shajahan AN, Riggins RB, Clarke R. The role of X-box binding protein-1 in tumorigenicity. Drug News Perspect. 2009;22(5):241-6.","DOI":"10.1358\/dnp.2009.22.5.1378631"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Kourdova LT, Miranda AL, Ovejero M, Anastas\u00eda A, Genti-Raimondi S, Racca AC, Panzetta-Dutari GM. Kr\u00fcppel-like factor 6 involvement in the endoplasmic reticulum homeostasis of extravillous trophoblasts. Placenta. 2024;155:42-51.","DOI":"10.1016\/j.placenta.2024.08.002"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Eisvand F, Tajbakhsh A, Seidel V, Zirak MR, Tabeshpour J, Shakeri A. Quercetin and its role in modulating endoplasmic reticulum stress: A review. Phytother Res. 2022;36(1):73-84.","DOI":"10.1002\/ptr.7283"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Elekofehinti OO, Onunkun AT, Olaleye TM. Cymbopogon citratus (DC.) Stapf mitigates ER-stress induced by streptozotocin in rats via down-regulation of GRP78 and up-regulation of Nrf2 signaling. J Ethnopharmacol. 2020;262:113130.","DOI":"10.1016\/j.jep.2020.113130"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Elaimi A, Hanadi MB, Almutairi A, Alniwaider RA, Abulkaliq MA, Naga AS, Kadhem JA, Qamre A. Insights from the molecular docking analysis of GRP78 with natural compound inhibitors in the management of cancers. Bioinformation. 2023;19(1):39-42.","DOI":"10.6026\/97320630019039"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/5d144b4f2d89fd5d\/CRO-59938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:35:20Z","timestamp":1763620520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,40052c1046b3fad2,5d144b4f2d89fd5d.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025059938","relation":{},"ISSN":["0893-9675"],"issn-type":[{"value":"0893-9675","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}